PTAB statistics

PTAB Trial Statistics as of September 11, 2014

As of September 11, 2014, USPTO records show 1,993 AIA trial petitions filed since September 16, 2012 (1,771 IPR, 215 CBM, 2 PGR, 5 derivation). The Board had instituted trial on 785 petitions and denied 356 (68.8% instituted) and had issued 140 final written decisions. In fiscal year 2014 to that date, 1,405 petitions were filed.

Key Facts

As of
September 11, 2014
Fiscal year
FY2014
Petitions filed (cumulative)
1,993
Institution rate (cumulative)
68.8%
Petitions filed (FY2014 to date)
1,405
Data retrieved
October 31, 2026
On this page
  1. Cumulative Figures as of September 11, 2014
  2. Fiscal Year 2014 to Date
  3. Change Since August 7, 2014
  4. Trial Types Covered
  5. How These Figures Were Compiled
  6. Related Statistics

This page gives Patent Trial and Appeal Board trial figures as of September 11, 2014, which falls in fiscal year 2014 (October 1, 2013 to September 30, 2014). The cumulative figures run from September 16, 2012, when AIA trials began. The full year is covered on the FY2014 statistics page.

Cumulative Figures as of September 11, 2014

Events from September 16, 2012 to September 11, 2014, by trial type:

MeasureIPRPGRCBMDERTotal
Petitions filed1,771221551,993
Institution decisions: instituted6950900785
Institution decisions: denied3030503356
Institution rate (by petition)69.6%—64.3%0.0%68.8%
Final written decisions1270130140
Terminations without a final written decisionCount
Settlements124
Adverse judgment0
Dismissed0
Other terminations4

Fiscal Year 2014 to Date

Events from October 1, 2013 to September 11, 2014:

MeasureIPRPGRCBMDERTotal
Petitions filed1,240215941,405
Institution decisions: instituted5180760594
Institution decisions: denied2560443303
Institution rate (by petition)66.9%—63.3%0.0%66.2%
Final written decisions1270120139
Terminations without a final written decisionCount
Settlements105
Adverse judgment0
Dismissed0
Other terminations3

Change Since August 7, 2014

Between the previous dated page (August 7, 2014) and September 11, 2014, 201 petitions were filed, 72 trials were instituted, 40 petitions were denied institution and 12 final written decisions issued. The cumulative institution rate moved from 69.3% to 68.8%.

Trial Types Covered

1,771 of the 1,993 petitions (88.9%) were for inter partes review, which challenges patent claims on prior-art grounds under 35 U.S.C. chapter 31. The remainder were for covered business method review (215), post-grant review under chapter 32 (2) and derivation proceedings (5). Institution standards differ by proceeding; see the threshold standards.

How These Figures Were Compiled

The figures are counted from USPTO Open Data Portal records retrieved on October 31, 2026, keeping only events dated on or before September 11, 2014: a petition by its filing date, an institution decision by its decision date, and a final written decision or termination by its date. They are a reconstruction from the current records, not the USPTO’s report of that date, and may differ from statistics the USPTO published at the time. Final written decision outcomes are not reported because the records state them for too few decisions. The methodology gives the counting rules in full.

Frequently Asked Questions

How many AIA trial petitions had been filed as of September 11, 2014?

USPTO records show 1,993 petitions filed from September 16, 2012 to September 11, 2014: 1,771 IPR, 215 CBM, 2 PGR and 5 derivation.

What was the PTAB institution rate as of September 11, 2014?

Cumulatively, 68.8% by petition: 785 instituted and 356 denied. In FY2014 to that date the rate was 66.2%.

Primary Sources

  1. USPTO Open Data Portal (PTAB trial proceedings and decisions data)
  2. USPTO Patent Trial and Appeal Board statistics
  3. 35 U.S.C. chapter 31 (inter partes review)
  4. 35 U.S.C. chapter 32 (post-grant review)
  5. 37 C.F.R. Part 42 (trial practice before the PTAB)

Educational information; not legal advice. Statutes, rules and USPTO practice change. Confirm against the primary sources and consult a registered patent practitioner before acting. Disclaimer.